+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Neomycin: a specific drug to study the inositol-phospholipid signalling system?



Neomycin: a specific drug to study the inositol-phospholipid signalling system?



Febs Letters 197(1-2): 285-288



Neomycin, an antibiotic previously thought to interact specifically with inositol-containing phospholipids, was found to inhibit IP3-mediated Ca2+ release from the intracellular stores of permeabilized insulinoma and liver cells. This inhibition could be relieved by increasing the IP3 concentration. Radiolabelled IP3 was found to bind tightly to columns prepared from neomycin covalently attached to glass beads. ATP was also bound by these columns. It is concluded that neomycin acts in biological systems as a weak anion exchanger and is therefore unsuitable for use as a specific tool to study the role of inositol phospholipids in intracellular signalling.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 040780222

Download citation: RISBibTeXText

PMID: 3485059

DOI: 10.1016/0014-5793(86)80343-x


Related references

Inositol phospholipid-dependent cellular signalling: opportunities for drug discovery. Drug Design and Delivery 6(1): 1-13, 1990

Signalling through CD28 T-cell activation pathway involves an inositol phospholipid-specific phospholipase C activity. Biochemical Journal 293: 835-842, 1993

Inositol phospholipid metabolism in Arabidopsis. Characterized and putative isoforms of inositol phospholipid kinase and phosphoinositide-specific phospholipase C. Plant Physiology 130(1): 22-46, 2002

Receptors with very high affinity for extracellular atp activate the inositol phospholipid signalling system in the hl60 human promyelocytic cell line. Federation Proceedings 46(3): 536, 1987

Occupation of extracellular atp receptors coupled to the inositol phospholipid signalling system induces differentiation of the hl60 and u937 myelomonocytic cell lines. FASEB Journal 2(5): ABSTRACT 6760, 1988

Evidence that chlorpromazine and prostaglandin E1 but not neomycin interfere with the inositol phospholipid metabolism in intact human platelets. Febs Letters 264(1): 33-36, 1990

Neomycin does not interfere with the inositol phospholipid metabolism, but blocks binding of alpha-thrombin to intact human platelets. Biochemical Journal 273(Pt 1): 241-243, 1991

Inositol phospholipid turnover in PAF transmembrane signalling. Lipids 26(12): 1028-1033, 1991

Neomycin inhibits platelet functions and inositol phospholipid metabolism upon stimulation with thrombin, but not with ionomycin or 12-O-tetradecanoyl-phorbol 13-acetate. European Journal of Biochemistry 177(1): 219-223, 1988

Does the inositol phosphate signalling system function in the heart? A comparison of inositol lipid turnover in cardiac and smooth muscle. Proceedings of the Western Pharmacology Society 33: 111-115, 1990

Modulation of inositol phospholipid signalling in human breast cancer cells by protein kinase c. Journal of Endocrinology 124(Suppl.), 1990

Evidence that stomatin-induced differentiation in Tetrahymena vorax is mediated by signalling through rapid inositol phospholipid turnover. Journal of Eukaryotic Microbiology 44(1): 10A, 1997

Neomycin inhibition of adenosine triphosphatase: evidence for a neomycin-phospholipid interaction. Antimicrobial Agents and ChemoTherapy 18(4): 532-535, 1980

Histamine-stimulated phospholipase C signalling in the adrenal chromaffin cell: effects on inositol phospholipid metabolism and tyrosine hydroxylase phosphorylation. Clinical and Experimental Pharmacology & Physiology 24(8): 624-631, 1997